Saturday 17 October 2026
Export WOK’s income statement to Excel — free account
WORK Medical Technology Group LTD
WOK Healthcare Medical Devices
WORK Medical Technology Group LTD’s revenue for fiscal 2025 (year ended September 2025) was $9.8 million, down 14.4% from fiscal 2024. Insiders bought in the last twelve months.
1.09
0.25
−18.66%
Follow WOK
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to September
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 3,260,000.00 | 206.00 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 8,446,000.00 | 6,000,000.00 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 226 | 216 | 238 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.06 | 0.05 | 0.04 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 20 | 20 | 14 | 12 | 10 | ||||
| Gross margin, % | — | — | — | — | — | 22.42 | 22.42 | 30.54 | 24.93 | 23.81 | |||||
| EBT | — | — | — | — | — | 1 | 1 | 0 | (4) | (1) | |||||
| EBT margin, % | — | — | — | — | — | 5.65 | 5.65 | 0.81 | (31.86) | (10.99) | |||||
| Net income | — | — | — | — | — | 0 | 1 | 0 | (4) | (1) | |||||
| Depreciation | — | — | — | — | — | — | 3 | 2 | 1 | 1 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 1.58 | 1.09 | 90.53 | 33.98 | ||||
| Earnings | — | — | — | — | — | — | 0.08 | 0.01 | (27.87) | (4.00) | |||||
| Cash flow | — | — | — | — | — | — | (0.18) | 0.18 | (17.53) | 21.55 | |||||
| Capex | — | — | — | — | — | — | (0.11) | (0.05) | (71.31) | (2.97) | |||||
| Free cash flow | — | — | — | — | — | — | (0.29) | 0.13 | (88.84) | 18.58 | |||||
| Book value | — | — | — | — | — | 0.00 | 0.90 | 0.88 | 126.44 | 73.03 | |||||
| Shares, m | — | — | — | — | — | — | 13 | 13 | 0 | 0 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/FCF | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.44) | (0.24) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | (2) | 2 | (2) | 6 | ||||
| Capex | — | — | — | — | — | — | (1) | (1) | (9) | (1) | |||||
| Free cash flow | — | — | — | — | — | — | (4) | 2 | (11) | 5 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 2 | 2 | 3 | 1 | 8 | ||||
| Total debt | — | — | — | — | — | — | 6 | 9 | 13 | 6 | |||||
| Net debt | — | — | — | — | — | (1) | 5 | 7 | 6 | 2 | |||||
| Shareholders’ equity | — | — | — | — | — | 11 | 11 | 11 | 16 | 21 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | 3.39 | 0.40 | (10.55) | (3.09) | ||||
| ROIC | — | — | — | — | — | 4.93 | 2.43 | 1.42 | (11.27) | (6.65) | |||||
| ROE | — | — | — | — | — | 0.00 | 8.36 | 1.01 | (25.82) | (5.76) | |||||
Negative figures in brackets.
Fiscal years to Sep 2025
Charts ten years each
WORK Medical Technology Group LTD vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| WOK WORK Medical Technology Group LTD | $6.0M | — | — | — | — | −948.94% (below 0%: shrinking) | — | — | |
| AMIX Autonomix Medical, Inc. | $5.7M | — (loss-making) | — | — | n/m | −36.10% (below 0%: shrinking) | — | 0.00% | Compare |
| NVNO enVVeno Medical Corporation | $5.5M | — (loss-making) | — (loss-making) | +0.32% (above 0%: growing) | n/m | +4.60% (above 0%: growing) | 0.00% | 0.00% | Compare |
| CODX Co-Diagnostics, Inc. | $5.3M | — (loss-making) | — (loss-making) | +1.96% (above 0%: growing) | n/m | +17.47% (above 0%: growing) | 72.73% | (3,733.17%) | Compare |
| TBIO Telesis Bio Inc. | $5.3M | — (loss-making) | — (loss-making) | −61.79% (below 0%: shrinking) | n/m | −17.96% (below 0%: shrinking) | 64.43% | (349.74%) | Compare |
| VNRX VolitionRX Limited | $5.3M | — (loss-making) | — (loss-making) | −1.97% (below 0%: shrinking) | n/m | +18.58% (above 0%: growing) | 100.00% | (1,042.39%) | Compare |
| TRIB Trinity Biotech PLC | $5.1M | — (loss-making) | — (loss-making) | +43.28% (above 0%: growing) | n/m | +75.24% (above 0%: growing) | 35.43% | (24.53%) | Compare |
| VVOS Vivos Therapeutics, Inc. | $4.8M | — (loss-making) | — (loss-making) | +34.90% (above 0%: growing) | n/m | +16.44% (above 0%: growing) | 57.31% | (93.63%) | Compare |
| INBS Intelligent Bio Solutions Inc. | $4.8M | — (loss-making) | 5.4× | +51.10% (above 0%: growing) | n/m | −31.59% (below 0%: shrinking) | 43.23% | (360.19%) | Compare |
| Median of peers | $5.3M | — | — | +1.96% | — | +10.52% | 57.31% | (221.68%) |
WORK Medical Technology Group LTD (WOK) key facts
- Concern: WORK Medical Technology Group LTD’s revenue for fiscal 2025 (year ended September 2025) was $9.8 million, down 14.4% from fiscal 2024.
- WORK Medical Technology Group LTD (WOK) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, WOK traded at $1.09, a market capitalization of $6.0 million.
- Return on equity was −5.76% and debt-to-equity 0.20.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1088.09 (safe zone) for fiscal 2025.